Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Anthracyclines induce epigenetic changes in ALDH1A that promote chemoresistance in AML, revealing a potential treatment strategy co-targeting ALDH1A inhibition with hypomethylating agents

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMühübe YazirACAndrada ConstantineascuIMIris Manosalva

Discussion

Loading...

Member takes

Overview

Molecular techniques reveal transcriptional role of ALDH1A in promoting chemoresistance in R/R AML, suggesting new treatment strategies.

Key Points

  • This research aims to explore the role of ALDH1A in chemoresistance in acute myeloid leukemia (AML).
  • Employ molecular and cellular techniques including ChIP-seq and RT-qPCR
  • Analyze ALDH1 expression in AML patient samples
  • Utilize murine leukemia models to evaluate treatment combinations
  • ALDH1A levels were significantly higher in refractory AML blasts compared to non-refractory cases
  • High ALDH1A expression correlated with reduced overall survival in AML patients
  • Inhibition of ALDH1A showed synergistic effects with hypomethylating agents in AML cell lines

Cite This Study

Yazir et al. (2025) studied this question.

synapsesocial.com/papers/69362f5d4fa91c937236dc4bhttps://doi.org/10.1182/blood-2025-214
View Full Paper
Ask AI
Bookmark
Share